Presentation is loading. Please wait.

Presentation is loading. Please wait.

Test 1Test 2Test 3Test 4Test 5Test 6 Sensitivity2.510.576.1608887.2 Specificity100 917098.296.3 PPV100 90.574.598.397.3 NPV475376.562.587.586.5 Performance.

Published byAustin Baker Modified over 9 years ago

Similar presentations

Presentation on theme: "Test 1Test 2Test 3Test 4Test 5Test 6 Sensitivity2.510.576.1608887.2 Specificity100 917098.296.3 PPV100 90.574.598.397.3 NPV475376.562.587.586.5 Performance."— Presentation transcript:

1 Test 1Test 2Test 3Test 4Test 5Test 6 Sensitivity2.510.576.1608887.2 Specificity100 917098.296.3 PPV100 90.574.598.397.3 NPV475376.562.587.586.5 Performance Characteristics of Six Commercial IgM Tests Relative to the CDC IgM Capture EIA* * Assay comparison study was an ARRA-funded project done in conjunction with the APHL Santa Clara County Public Health Department and Iowa State Hygienic Laboratory performed the testing.

2 Measles Specimens Referred to CDC for Confirmatory or Reference Testing – 2006 to 2011

3 National Center for Immunization and Respiratory Diseases Division of Viral Diseases Measles was laboratory-confirmed in 48 (87%) cases 20 (42%) by detection of measles-specific IgM antibodies only 24 (50%) by detection of measles-specific IgM antibodies and measles virus RNA 4 (8%) by detection of measles virus RNA only Laboratory Confirmed Measles Cases in USA: 2012

4 National Center for Immunization and Respiratory Diseases Division of Viral Diseases Laboratory Confirmed Measles Cases in the USA, 2013 with Laboratory Results Shared with CDC IgM only32 (45%) IgM and PCR26 (37%) PCR only12 (17%) Total70

Download ppt "Test 1Test 2Test 3Test 4Test 5Test 6 Sensitivity2.510.576.1608887.2 Specificity100 917098.296.3 PPV100 90.574.598.397.3 NPV475376.562.587.586.5 Performance."

Similar presentations

Nick Curry, MD, MPH Infectious Diseases Prevention Section

Nick Curry, MD, MPH Infectious Diseases Prevention Section
DCLS Influenza Laboratory Testing Denise M. Toney, Ph.D. Commonwealth of Virginia Division of Consolidated Laboratory Services H & M Panel – May 2009.

DCLS Influenza Laboratory Testing Denise M. Toney, Ph.D. Commonwealth of Virginia Division of Consolidated Laboratory Services H & M Panel – May 2009.
Diagnosis and Management of Acute HIV Infection HIV Clinical Guidelines from the New York State Department of Health AIDS Institute January 2010 HIV CLINICAL.

Diagnosis and Management of Acute HIV Infection HIV Clinical Guidelines from the New York State Department of Health AIDS Institute January 2010 HIV CLINICAL.
Comparative Performance of Dual 3rd Generation Immunoassays as a Potential Laboratory-Based HIV-1/2 Testing Strategy. B. Bennett, S. Fordan, O. David,

Comparative Performance of Dual 3rd Generation Immunoassays as a Potential Laboratory-Based HIV-1/2 Testing Strategy. B. Bennett, S. Fordan, O. David,
Utilizing a Non-Commercial Real- Time PCR to Detect HIV-1 RNA in HIV Antibody Negative Diagnostic Sera Submitted to The Maryland Public Health Laboratory.

Utilizing a Non-Commercial Real- Time PCR to Detect HIV-1 RNA in HIV Antibody Negative Diagnostic Sera Submitted to The Maryland Public Health Laboratory.
Comparison of the HIV LIA vs WB on HIV-Negative Samples CDC-HIV Diagnostics Meeting “New Diagnostic Technologies” Dec 5-7, 2007 Dr. John Kim National Laboratory.

Comparison of the HIV LIA vs WB on HIV-Negative Samples CDC-HIV Diagnostics Meeting “New Diagnostic Technologies” Dec 5-7, 2007 Dr. John Kim National Laboratory.
Mosquito-borne Arbovirus Surveillance in West Virginia Rachel Radcliffe, DVM, MPH CDC Career Epidemiology Field Officer Division of Infectious Disease.

Mosquito-borne Arbovirus Surveillance in West Virginia Rachel Radcliffe, DVM, MPH CDC Career Epidemiology Field Officer Division of Infectious Disease.
Blood Products Advisory Committee Meeting Harold S. Gaithersburg, MD December 14, 2010 Harold S. Margolis, MD Chief, Dengue Branch Centers for Disease.

Blood Products Advisory Committee Meeting Harold S. Gaithersburg, MD December 14, 2010 Harold S. Margolis, MD Chief, Dengue Branch Centers for Disease.
A Word about… Rapid Influenza Diagnostic Testing (RIDT) Kelly L. Moore, MD, MPH Director, TN Immunization Program TDH Regional Epidemiology Meeting Montgomery.

A Word about… Rapid Influenza Diagnostic Testing (RIDT) Kelly L. Moore, MD, MPH Director, TN Immunization Program TDH Regional Epidemiology Meeting Montgomery.
Improved Reflexive Testing Algorithm for Hepatitis C Infection Using Signal-to-Cutoff Ratios of a Hepatitis C Virus Antibody Assay K.K.Y. Lai, M. Jin,

Improved Reflexive Testing Algorithm for Hepatitis C Infection Using Signal-to-Cutoff Ratios of a Hepatitis C Virus Antibody Assay K.K.Y. Lai, M. Jin,
Use of avidity reagent. Panbio Buffered Avidity Reagent Mild protein-denaturing solution that may be useful in differentiating recent infections from.

Use of avidity reagent. Panbio Buffered Avidity Reagent Mild protein-denaturing solution that may be useful in differentiating recent infections from.
Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.

Routine HIV Screening in Health Care Settings David Spach, MD Clinical Director Northwest AIDS Education and Training Center Professor of Medicine, Division.
Epidemiology of HIV-2 infection in the U.S, 1996-2006 Lata Kumar MS, MPH Richard Selik MD Division of HIV/AIDS Prevention National Center for HIV/AIDS,

Epidemiology of HIV-2 infection in the U.S, Lata Kumar MS, MPH Richard Selik MD Division of HIV/AIDS Prevention National Center for HIV/AIDS,
What is one of the most contagious diseases? Measles 2015 Dr. Michael Levy.

What is one of the most contagious diseases? Measles 2015 Dr. Michael Levy.
HIV-1/HIV-2 COMBINATION SCREENING AND OUTCOMES OF FOLLOW UP William R. Oleszko, Ph.D. Associate Director, Public Health Laboratory Department of Health.

HIV-1/HIV-2 COMBINATION SCREENING AND OUTCOMES OF FOLLOW UP William R. Oleszko, Ph.D. Associate Director, Public Health Laboratory Department of Health.
Progression of HIV Infection Cases Diagnosed in Florida Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control.

Progression of HIV Infection Cases Diagnosed in Florida Through 2012 Florida Department of Health HIV/AIDS and Hepatitis Section Division of Disease Control.
Hepatitis web study H EPATITIS W EB S TUDY Hepatitis A: Epidemiology Presentation Prepared by: David Spach, MD and Nina Kim, MD Last Updated: May 31, 2011.

Hepatitis web study H EPATITIS W EB S TUDY Hepatitis A: Epidemiology Presentation Prepared by: David Spach, MD and Nina Kim, MD Last Updated: May 31, 2011.
Www.aids2014.org Alere TM HIV Combo Yuko Tamanoue, Product Development Department.

Alere TM HIV Combo Yuko Tamanoue, Product Development Department.
Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health Attending Physician Ronald Reagan Medical Center Center for World Health and Division.

Jeffrey D. Klausner, MD, MPH Professor of Medicine and Public Health Attending Physician Ronald Reagan Medical Center Center for World Health and Division.
Virology 22-2-11.

Virology

Similar presentations

Ads by Google